RPRD1B and neoplasm: RPRD1B was upregulated in 20/36 (55.6%) GC primary tumor tissues (P = 0.0061) and 9/12 (75%) metastatic lymph nodes (P < 0.0001) compared with the corresponding nontumor tissues (Fig. 1B).